Proallostera is dedicated to unlocking new therapeutic pathways by targeting the proteasome system in neurodegenerative diseases
“We are a precision neurotherapeutics company advancing next-generation therapies that restore protein homeostasis by targeting the proteasome system—aiming to slow, halt, or reverse neurodegeneration in Alzheimer’s disease and related disorders.”